WuXi Biologics reports changes in issued shares

WuXi Biologics (HKEX:2269) reported changes in its issued ordinary shares as of May 2, 2025. The company issued 40,000 new shares under a share scheme and 5,180,000 new shares through the exercise of pre-IPO share options. Both issuances were priced at HKD 1.29 per share. These transactions increased the total number of issued shares to 4,122,090,191 from a previous balance of 4,116,870,191 as of April 30, 2025. Additionally, the company has ongoing repurchases for cancellation not yet cancelled, with various transactions throughout January and April, at prices ranging from HKD 17.43 to HKD 20.03 per share. These repurchases total 60,539,500 shares, but have not yet been cancelled. WuXi Biologics confirms that all relevant regulations and requirements have been met for these share issuances and potential cancellations.